Results 41 to 50 of about 183 (86)

Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome. [PDF]

Int J Womens Health
Suwarsa O, Hidayah RMN, Avriyanti E, Sutedja E, Pangastuti M, Firdaus CP, Achdiat PA, Pratama DG.   +7 more
europepmc   +1 more source

Morphea: progress to date and the road ahead. [PDF]

Ann Transl Med, 2021
Abbas L, Joseph A, Kunzler E, Jacobe HT.
europepmc   +1 more source

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review. [PDF]

Pediatr Rheumatol Online J
Zheng R, Zou L, Li SC, Lu M.
europepmc   +1 more source

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases. [PDF]

Front Med (Lausanne)
Volc S, Martus P, Schefzyk M, Günther C, Moinzadeh P, Susok L, Ferrer RA, Zago M, Pfeiffer C.   +8 more
europepmc   +1 more source

Morphea: The 2023 update. [PDF]

Front Med (Lausanne), 2023
Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ.   +4 more
europepmc   +1 more source

A systematic review of therapeutic procedures for the treatment of morphea and systemic sclerosis. [PDF]

Lasers Med Sci
Jafarzadeh A, Leisi A, Goodarzi A.
europepmc   +1 more source

Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea. [PDF]

J Transl Med, 2022
Zhu JL, Paniagua RT, Chen HW, Florez-Pollack S, Kunzler E, Teske N, Rainwater YB, Li QZ, Hosler GA, Li W, Ramirez DMO, Monson NL, Jacobe HT.   +12 more
europepmc   +1 more source

The role of selected cytokines from the interleukin 1 family in the pathophysiology of morphea. [PDF]

Arch Dermatol Res
Cieplewicz-Guźla P, Kowalczyk MJ, Dańczak-Pazdrowska A, Żaba R, Wegner J, Polańska A.   +5 more
europepmc   +1 more source

Ultrasound Utility in the Management of Morphea: A Comprehensive Review. [PDF]

Indian Dermatol Online J
Khan R, Khachemoune A.
europepmc   +1 more source

The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity. [PDF]

Cureus
Al-Nasrawi AN, Abdulkareem AS, Mohammed Ali MN.   +2 more
europepmc   +1 more source